RAPT Therapeutics Inc.
World Rank (Jan-05-2024)
9,736
Market Cap (Jan-05-2024)
0.807 Billion USD
World Rank (Jul-30-2023)
9,835
Market Cap (Jul-30-2023)
0.812 Billion USD
World Rank (Dec-25-2022)
11,440
Market Cap (Dec-25-2022)
0.583 Billion USD
World Rank (Jan-07-2022)
8,681
Market Cap (Jan-07-2022)
1.16 Billion USD
Annual Revenue in USD
2 Million USD
Annual Net Income in USD
-84 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
RAPT Therapeutics is a Clinical Stage Immunology Based Biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. It is having 68 employees as on 2019. The headquarters is in USA.
Company Website